2008
DOI: 10.1038/sc.2008.162
|View full text |Cite
|
Sign up to set email alerts
|

ASIA impairment scale conversion in traumatic SCI: is it related with the ability to walk? A descriptive comparison with functional ambulation outcome measures in 273 patients

Abstract: Study design: Prospective multicenter longitudinal cohort study. Objectives: To determine the relationship between improvements of the American Spinal Injury Association/International Spinal Cord Society (ASIA/ISCoS) neurological standard scale (AIS) outcome measure and improvements of functional ambulatory outcome measures in patients with traumatic spinal cord injury (SCI). Setting: European multicenter study of human SCI (EM-SCI). Methods: In 273 eligible patients with traumatic SCI, acute (0-15 days) and c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
73
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 108 publications
(76 citation statements)
references
References 22 publications
2
73
0
1
Order By: Relevance
“…Finally, although the AIS is a recognizable benchmark for the baseline neurologic assessment of the acute SCI patient, the AIS is a questionable outcome measurement, as it does not address the functional capabilities. 32 As previously mentioned, the diagnostic capabilities of the currently available biomarkers will not exceed that of the initial neurological assessments, so long as they are compared with these neurological assessments as the comparative gold standard. 5 Future studies are needed to determine whether structural biomarkers could be used as diagnostic markers in those SCI patients where a valid baseline neurological assessment cannot be obtained, or if they could better predict long-term outcome than this initial neurological evaluation.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, although the AIS is a recognizable benchmark for the baseline neurologic assessment of the acute SCI patient, the AIS is a questionable outcome measurement, as it does not address the functional capabilities. 32 As previously mentioned, the diagnostic capabilities of the currently available biomarkers will not exceed that of the initial neurological assessments, so long as they are compared with these neurological assessments as the comparative gold standard. 5 Future studies are needed to determine whether structural biomarkers could be used as diagnostic markers in those SCI patients where a valid baseline neurological assessment cannot be obtained, or if they could better predict long-term outcome than this initial neurological evaluation.…”
Section: Discussionmentioning
confidence: 99%
“…An important starting place for planning a locomotor rehabilitation program is the ability to predict likely future walking ability, as well as to anticipate responsiveness to training, Because AIS conversion between the acute and chronic phases of SCI appears to have little relationship with improvement in walking capacity, 125 a focus on prediction of walking related outcomes is more clinically meaningful than predicting AIS conversion. Of the various measures available to assess walking function, walking speed and distance have been identified as the measures most responsive to change.…”
Section: Predicting Future Walking Function and Forecasting Responsivmentioning
confidence: 99%
“…In this study, the neurological level of injury (low vs. high cervical) was not a significant predictor of the FI in the logistic regression analysis. This can be explained by the fact that the neurological recovery does not necessarily parallel the functional recovery [20,22].…”
Section: Discussionmentioning
confidence: 99%